Matthews International Capital Management’s Burning Rock Biotech BNR Stock Holding History

Matthews International Capital Management’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-152,131	Closed	-$14.1M	–	41
2022 Q1	$14.1M	Sell	152,131 -4,560	-3%	-$396K	1.96%	15
2021 Q4	$14.9M	Sell	156,691 -42,350	-21%	-$5.8M	1.56%	16
2021 Q3	$35.6M	Hold	199,041	–	–	2.16%	12
2021 Q2	$58.6M	Buy	199,041 +30,450	+18%	+$9.01M	2.44%	12
2021 Q1	$45.4M	Hold	168,591	–	–	1.9%	14
2020 Q4	$38.9M	Buy	168,591 +30,364	+22%	+$8.15M	2.07%	16
2020 Q3	$34.7M	Sell	138,227 -43,030	-24%	-$10.2M	2.34%	15
2020 Q2	$49M	Buy	+181,257	New	+$49.7M	3.81%	9

Other funds holding BNR

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Matthews International Capital Management's BNR Position: Q2 2022 in Review

Matthews International Capital Management sold out of Burning Rock Biotech (BNR) in Q2 2022, closing a stake of 152,131 shares — an estimated $14.1M sold.

Matthews International Capital Management first reported a position in BNR in Q2 2020 and held it in 8 quarters. The position peaked at $58.6M in Q2 2021. 50 funds tracked by Wall St. Rank hold BNR as of Q2 2022.

Matthews International Capital Management reported no remaining Burning Rock Biotech position as of Q2 2022 after selling out during the quarter.
Matthews International Capital Management sold 152,131 Burning Rock Biotech shares in Q2 2022, an estimated $14.1M.
Matthews International Capital Management first reported a position in Burning Rock Biotech in Q2 2020 and held it in 8 quarters.
Matthews International Capital Management's Burning Rock Biotech position peaked at $58.6M in Q2 2021.
50 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2022.

Based on Matthews International Capital Management's 13F filing for Q2 2022, filed 13 Jul 2022.